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Abstract	
A novel nanocomposite material which combines the biocompatible, elastomeric, natural, 
biodegradable homopolymer, poly(3-hydroxyoctanoate), P(3HO), with haemostatic and 
antibacterial bioactive glass nanoparticles (n-BG), were developed as a matrix for skin related 
applications. P(3HO) is a unique member of the family of natural polyhydroxyalkanoate 
biopolymers. The P(3HO)/n-BG composite films were fabricated using the solvent casting 
method. Microstructural studies revealed n-BG particles both embedded in the matrix and 
deposited on the surface which introduced nanotopography and increased its hydrophilicity. 
The composite exhibited an increase in the Young’s modulus when compared to the control, 
yet maintained flexible elastomeric properties. These changes in the surface topography and 
chemistry of the composite system led to an increase of protein adsorption and 
cytocompatibility for the seeded human keratinocyte cell line (HaCaT). The results from this 
study demonstrated that the fabricated P(3HO)/n-BG composite system is a promising novel 
matrix material with potential applications in skin tissue engineering and wound healing.  
Key	words:	Poly(3-hydroxyoctanoate), bioactive glass, composites, skin tissue 
engineering, wound healing		
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1. Introduction	
The skin is the largest organ in humans, acting as a protective interphase between the human 
body and the surrounding, which protects underlying organs and also plays a pivotal role in 
fluid homeostasis, sensory detection and self-healing.[1-4] When the structural integrity of the 
skin is damaged or lost, impairment of the skin functions occur resulting in minor to 
significant disability and may even lead to death.[4-7] Such large skin defects therefore require 
immediate intervention to protect the wound from infections and to replace the damaged and 
lost skin.8 Autografts and allografts have been conventionally used to treat burns and other 
full thickness wounds. For dermal wound healing use of autografts is a “gold standard” as no 
immune rejection is encountered.[9] However, this approach suffers from limited availability 
and the risk of donor site morbidity.  Allografts, though not limited by availability, pose risks 
of disease transmission and immune rejections.[10-13] 
A wide range of research is now being undertaken on the development and clinical use of 
tissue engineered skin grafts to overcome the limitation of autografts and allografts. In this 
tissue engineering approach, the relevant skin cells are seeded and populated in a suitable 
matrix designed to mimic the skin’s natural extracellular matrix (ECM) with or without the 
use of additional chemical cues. The skin cell matrix construct is then grafted on to the wound 
(epidermal graft); cells then proliferate from the matrix to the wound bed forming cell clusters 
and ultimately the normal epidermis.[14, 15] The matrix thus provides healthy replacement cells, 
protection to the wound, until it is degraded or absorbed [14, 15], and elasticity and mechanical 
support to the regenerating skin. Amongst the natural materials, one promising candidate for 
designing the matrix support, are the polyhydroxyalkanoate (PHA) family of biopolymers [16] 
PHAs are polyesters of 3-hydroxyacids biosynthesized from bacteria using a variety of carbon 
sources.[17] The PHAs may be short chain length (scl), containing C3 to C5 carbon atoms or 
medium chain length (mcl) containing C6 to C14 carbon atoms in the monomer units.  PHAs 
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are a highly promising family of biodegradable biomaterials, yet to be extensively used for 
biomedical applications. They have a wide range of chemical structures leading to mechanical 
properties ranging from hard and brittle to soft and elastomeric, suitable for various tissue 
engineering (TE) applications.[18] Their degradation products are much less acidic than those 
of Polylactic acid, PLA and Poly(lactic-co-glycolic acid), PLGA, leading to higher 
biocompatibility. Also, their degradation occurs by surface degradation, as opposed to the 
bulk degradation of PLA or PLGA, leading to highly controlled degradation, highly desirable 
for TE applications.  
In this work we have used a novel homopolymer, poly(3-hydroxyoctanoic acid), P(3HO), an 
mcl-PHA, which is unique and has been produced and described for the first time by Rai et 
al.[19] The P(3HO) is biosynthesized using the bacteria P. mendocina grown on an octanoate 
feed.[19] The polymer P(3HO) has promising properties of flexible elastomeric nature and 
biocompatibility amenable for soft tissue engineering such as skin tissue engineering.[20] The 
highly flexible nature of P(3HO) would enable its application into wound beds located in 
difficult contours of the body and also sustain and recover from multiple deformations 
without adversely affecting the surrounding tissues. Additionally, due to its biodegradable 
nature, P(3HO) would provide a temporary mechanical support for the healthy cells without 
additional surgical intervention for its subsequent removal.   
However, PHAs, including P(3HO), are relatively hydrophobic in nature and are not as highly 
bioactive.[21] In recent years numerous studies have been carried out to study the cumulative 
effect of combining an inorganic phase with biodegradable polymers to develop composite 
systems.[22] Bioactive glasses have been shown to form tenacious bonds to both hard and soft 
tissues; bonding is enabled by the formation of a hydroxyapatite (similar to biological apatite) 
layer on the glass surface on exposure to biological fluids both in vitro and  in vivo.[23, 24] 
Incorporation of such bioactive glasses into polymer matrices improves the hydrophilicity [25, 
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26]  and also allows tailorability of the mechanical properties and degradation kinetics of the 
composite systems to match with the regenerative rate of the target tissue.[22] Bioactive glasses 
being bactericidal [27] are particularly important as one of the major challenges in healing 
chronic wound is the prevention of infection from opportunistic pathogens.[28] Bioactive 
glasses have also been reported to support angiogenesis which is crucial for stimulating 
neovascularisation of tissue engineered constructs.[29, 30] Furthermore, mesoporous bioactive 
glass particles have also exhibited haemostatic activity under in vitro conditions.[31] 
Although bioactive glasses (microsize and nanosize), especially Bioglass®, have been 
incorporated into PHAs, these have been mainly scl-PHAs, in order to develop composites 
with focus on bone tissue engineering and drug delivery applications.[25, 32] In this study 
therefore we sought to investigate, for the first time, the potential of a novel nanocomposite 
system of poly(3-hydroxyoctanoate), a promising new biodegradable and biocompatible 
natural polymer, with bioactive glass nanoparticles (nBG) as a unique matrix support for skin 
tissue engineering applications. 
2. Materials	and	Methods		
2.1. Materials			
The homopolymer poly(3-hydroxyoctanoate), P(3HO), used in this study was biosynthesized 
using P. mendocina grown in octanoate feed.[19] The bioactive glass particles (n-BG) used 
were of nanosize (average diameter, ~30 nm) with the following composition in wt% : SiO2, 
46.08 % ; Na2O, 2.96 % ; CaO, 28.18 % and P2O5, 3.77 %.[25] The fabrication of these 
nanoparticles by flame spray synthesis and the physical characterisation has been presented 
by Brunner et al.[33]  
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2.2. Fabrication	of	films	
Fabrications of the films were carried out using the solvent casting method. For the 
fabrication of the P(3HO) neat films (control), 5 and 10 wt % of the polymer was thoroughly 
dissolved in 10 mL of CHCl3. The polymer solution was then filtered and cast into glass petri 
dishes (40 mm diameter). The films were then left to air dry at room temperature for 1 week 
followed by freeze drying for 10 days. These P(3HO) neat films will be referred as 5 wt% 
neat and 10 wt% neat. 
For the fabrication of the P(3HO)/n-BG composite films, 1 wt % of n-BG was added to the 
filtered 5 wt% and 10 wt% polymer solutions corresponding to a n-BG concentration of   
17 %  v/v and 9 % v/v respectively. The polymer/n-BG mixtures were then sonicated using a 
sonicator (Philip Harris Scientific) at a pulse rate of 2 pulses/sec for a period ranging between 
1 and 2 minutes. The composite films were then cast and prepared similarly like that of the 
control films.  These composite films were referred to as 5 wt% and 10 wt % composite.  
2.3. Microstructural	studies	
2.3.1. Scanning	electron	microscopy	(SEM)	
Microstructural studies for the surface topography were carried out using a JEOL 5610LV 
scanning electron microscope. The samples were placed on 8 mm diameter aluminium stubs 
and then sputter coated with gold using an EMITECH-K550 sputtering device. An operating 
pressure of 7 x 10-2 bar and deposition current of 20 mA for 2 minutes were used. SEM 
images were taken with an acceleration voltage of 15 kV (maximum) to avoid incineration of 
the polymer due to the beam heat. 
2.3.2. White	light	interferometry	study	(Zygo®)		
White light interferometry was used to obtain 3D images of the surface topography of 
samples by means of the analyzer Zygo® (New View 200 OMP 0407C). This measurement 
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allowed the quantification of the roughness and also a visual investigation of the topography 
of the surfaces.  
2.3.3. Contact	angle	study	
Static contact angle measurements were carried out to evaluate the wettability i.e. 
hydrophilicity of the fabricated films. A gas tight micro syringe was used to place an equal 
volume of water (<10 µl) on every sample by means of forming a drop. Photos (frame interval 
of 1 second, number of frames = 100) were taken to record the shape of the drops. Water 
contact angles on the specimens were measured by analysing the recorded drop images using 
the Windows based KSV CAM software. Four repeats for each sample were carried out. The 
experiment was done on a KSV CAM 200 optical contact angle meter (KSV Instruments Ltd). 
2.4. Mechanical	properties	
Tensile testing was performed using a Perkin–Elmer dynamic mechanical analyzer at room 
temperature. Sample strips (N=6) were of 10 mm length and 4 mm width, cut from the solvent 
cast films. The initial load was set to 1 mN and then increased to 6000 mN at the rate of 200 
mN min-1. Young’s modulus, stress and strain were recorded during the test.  
2.5. Thermal	properties	
The thermal properties of the fabricated materials,  i.e. glass transition temperature (Tg) and 
melting temperature (Tm), were measured by carrying out differential scanning calorimetry 
(DSC) using a Perkin Elmer Pyris Diamond DSC (Perkin Elmer Instrument). The amount of 
polymer (N=3 per sample type) used for the study ranged from 8 to 10 mg and the sample was 
encapsulated in standard aluminium pans. All tests were conducted under inert nitrogen. The 
samples were heated/cooled/heated at a heating/cooling rate of 20oC min-1 between  
-57oC and 100oC.Thermal gravimetric analysis (TGA) was conducted using a Stanton 
Redcroft STA-780 Series Thermal Analyzer, to determine the degradation profile. Scans were 
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performed between 10 and 1200oC and at a rate of 5oC min-1 Measurements were made over 
three repeats using a sample mass of 4 mg. 
2.6. In	vitro	degradation	studies	
Degradation behaviour of the fabricated 2D films was studied for a period of 1, 2 and 4 
months at 37°C in phosphate buffered saline (PBS) and Dulbecco’s Modified Eagles Medium 
(DMEM). PBS was chosen since it is one of the buffer systems that regulate the acid or base 
balance in the body. DMEM was the culture medium used for the cytocompatibility studies 
with HaCaT cells and the fabricated films.  
2.6.1. Water	uptake,	weight	loss,	pH	measurements	and	surface	studies	
The degradation kinetics of the fabricated 2D films was determined by measuring the % water 
uptake or absorption (% WA) and % weight loss (% WL). All samples were first weighed to 
obtain the dry weight Mo, dry (Mo, dry, the initial weight of the sample), immersed in the 
respective media and kept under static conditions at 37oC. At each prescheduled incubation 
time point the films were collected and analysed for water absorption (% WA) and weight 
loss (% WL) behaviour. For measuring the % WA, the immersed samples were removed at 
given time points, the surface gently wiped with a tissue paper and then weighed to obtain  
Mt wet (Mt wet,  the weight of the samples after immersion in the medium). Similarly, for 
measuring the % WL, the samples were withdrawn from the medium, washed several times 
with deionised water and dried at 37oC overnight and subsequently weighed dry, to obtain  
Mt dry (Mt dry, the dry weight of the samples after immersion in the media followed by drying). 
Water absorption and weight loss were calculated using the following equations: 
 
 
 
 
% WA = [(Mt wet-Mt dry)/Mt dry]100 
 % WL = [(Mo dry-Mt dry)/Mo dry] 100 
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The media in which the films were incubated were changed every week for the first one 
month and every 14-16 days progressively. The pH of this incubated media was recorded. 
Surface degradation via SEM of the in vitro degraded films was carried out as described 
above.  
2.7. Protein	adsorption	studies	
Protein adsorption assay was performed using foetal bovine serum (FBS). Square films,  
(1 cm2 in area), were incubated in 400 µL of undiluted FBS, at 37oC, for 24 hrs. After 
incubation, the samples were rinsed with PBS, three times. The samples were then incubated 
in 1 mL of 2% sodium dodecyl sulphate (SDS) in PBS for 24 hrs at room temperature and 
under vigorous shaking to further collect the adsorbed proteins. The amount of total protein 
adsorbed on the surface of the samples was quantified using a commercial protein 
quantification kit (Pierce, Rockford, IL). The optical density of the samples was measured 
spectrophotometrically at 562 nm against a calibration curve using bovine serum albumin as 
per the manufacturer’s protocol. The samples incubated in PBS were used as a negative 
control. The assay was carried out in triplicates. 
2.8. In	vitro	cytocompatibility	study	
The in vitro cell culture studies were carried out on the fabricated films (N=3 per sample type) 
using the Human keratinocyte cell line (HaCaT), which was cultured in DMEM growth 
medium, supplemented with 10% foetal calf serum, 1% glutamine and 1% penicillin and 
streptomycin solution. The cells were incubated at 37oC in a 5% CO2 humidified atmosphere 
with the culture medium being changed every 2 days. The fabricated 2D films, 1 cm2 in area, 
were UV sterilised for 30 minutes on each side and exposed in culture medium for 12 h in 
order to passivate the surfaces.  20,000 cells were seeded per cm2 of the films, kept in 24 well 
plates. The cells were analysed after 1, 4 and 7 days for cell adhesion, proliferation and 
morphology. Cell adhesion and proliferation studies were carried out using the Neutral Red 
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(NR) assay as described elsewhere.47 The total NR uptake was a measure of the cell 
proliferation and viability (% NR uptake is directly proportional to the number of live and 
uninjured cells and was compared to a control population grown on  tissue culture plates. The 
control was normalised to 100%. The samples for SEM analysis of cell morphology were 
prepared as described in Misra et al.[25] 
2.9. In	vitro	haemostatic	study	using	Thromboelastograph®,	
TEG®	
The haemostatic effect of the n-BG 45S5® was studied by thromboelastography using a TEG® 
5000 series Hemostasis Analyzer (Medicell Ltd, London, UK). Briefly, 20 µl of 0.2M CaCl2 
was added to 360 µl of citrated whole blood, followed by controlled amounts of n-BG. The 
following clotting parameters were then monitored i.e. the R time (reflecting the time delay 
before the clotting process begins to be detectable), alpha angle (reflecting the rate at which 
clotting proceeds) and maximum amplitude (reflecting the strength of the formed clot). Three 
different amounts of n-BG 45S5® i.e. 1, 2 and 4 mg were used for the study, in order to look 
for dose-related changes.  
 
2.10. Statistical	analysis	The	data	sets	have	been	expressed	along	with	their	mean	standard	deviation.	The	data,	where	 appropriate,	 were	 compared	 using	 the	 student’s	 t-test	 and	 differences	 were	considered	significant	when	*p	<	0.05.		
 
3. Results and discussion 
The fabrications of the matrices, P(3HO) neat (control) and P(3HO)/n-BG composite films 
was successfully carried out using the solvent casting method. The surface morphology 
assessment by SEM revealed that the P(3HO) control films (Figure 1(a-b)) possessed a 
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smooth surface.  However, in the case of P(3HO)/n-BG composite films, the incorporation of 
the n-BG changed the surface morphology by introducing nanotopographical features 
(Figures 1(c-d)). n-BG particles were found embedded in the matrix and deposited on the 
surface of the composite.  
 
Figure 1 
 
This incorporation of artificial nanotopography onto the surface of the P(3HO)/n-BG 
composite films resulted in enhanced roughness, as confirmed by surface scans, using white 
light interferometry (Zygo®). A typical root-mean-square-average (RMS) roughness value of 
0.440 µm was determined for the 5wt% composite film as opposed to 0.238 µm for the 5 wt% 
neat (control) film. Roughness measurements of the 10 wt% films were not assessed; however 
similar observation of increased roughness of the 10 wt% composite could be expected. Static 
contact angle (θH2O ) measurements for the control and composite films were as follows:  
5 wt % neat, θH2O =  77o; 5 wt % composite = 75o, 10 wt% neat = 78 o and 10 wt % 
composite = 76o. For the composite films, incorporation of n-BG resulted in increased 
wettability as revealed by the decreased static contact angle (n=4, *p<0.05). 
To engineer a successful skin tissue for wound healing, the skin graft must provide epidermal 
coverage followed by subsequent restoration of the dermal layer. This is because epidermal 
coverage on its own fails to restore structural and functional integrity of the skin, thereby 
resulting in fragility of the graft, wound contraction and scar formation. In order to achieve 
this restoration of the dermis layer, a suitable matrix/scaffold to provide flexible and stable 
support to the epidermal coverage and nutrients to the keratinocytes in the epidermal layer is 
required.[4, 8] This stability of the keratinocyte attachment onto the wound bed becomes more 
challenging if the location of such wound beds is in difficult contours of the body. In such 
cases having a flexible and elastomeric support is essential. Therefore, in this context the 
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observation of increased Young’s modulus and strength of the P3(HO)/n-BG nanocomposites 
due to the incorporation of the n-BG, with a concomitant maintenance of the elastomeric and 
flexible properties is an ideal, highly desirable outcome. The stress-strain curves of the 
fabricated films resembled that of elastomeric materials. (Stress strain profiles are provided as 
supplementary information, Figure S.1). The Young’s modulus value calculated from the 
curves were: 5 wt% composite film = 3 ± 1 MPa, 5 wt% neat(control) film = 1.4 ± 0.6 MPa, 
10 wt% composite film = 4 ±1 MPa and 10 wt% neat (control) film = 3.1 ± 0.7 MPa.  Under 
the experimental conditions of this study, only the 5 wt% composite and 5 wt% neat films 
failed during the test; the tensile strength for the 5 wt% composite film was 3.3 MPa and that 
of the 5 wt % neat (control) film was 1.8 MPa. The % elongation of these films was: 5 wt% 
composite film = 236 % ± 10 and 5 wt% neat (control) film = 278 % ± 10. The % elongation 
at the end of the test for the other films were, 10 wt% composite film = 222 % ± 6 and 10 
wt% neat (control) film = 257 % ± 9.  
The increased Young’s modulus and tensile strength of the composites owing to n-BG 
incorporation was similar to that observed for P(3HB)/n-BG composites [25], nanoscale 
tricalcium phosphate/PLGA composites [33] and poly(glycerol sebacate)/ Bioglass® 45S5 
composites.[34] This effect can be explained first by the efficient infiltration and sealing of the 
pores in the polymer matrix by the n-BG, thereby strengthening the whole composite 
structure. Secondly, the incorporation of the n-BG into the polymer matrix provides a higher 
interfacial surface area which enhances the load transfer between the polymer matrix and the 
stiff n-BG inclusions. The P(3HO)/n-BG composite developed also showed reduction in their 
melting temperature (Table 1), thus corresponding to a decrease in their crystallinity when 
compared to P(3HO) control films. This decrease in crystallinity possibly occurred due to the 
incorporation of n-BG particles in the crystalline portion of the polymer matrix which resulted 
in disruption and reduction of the ordered arrangement of the P(3HO) polymeric chains in the 
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composite. A similar observation of decrease in the Tm was also reported when n-BG was 
incorporated into the P(3HB) matrix. The melting temperature reduced from 172oC for 
P(3HB) neat film to  156oC, 157oC and 155oC for P(3HB) containing 10, 20 and 30 wt% of  
n-BG, respectively.[25] 
Table 1 
Thermogravimetry analysis (provided as supplementary information, Figure S.2) revealed that 
the P(3HO) control films lost all its weight at 300oC, similar to that of P(3HB-co-3HHx).[35] 
Incorporation of n-BG reduced the degradation temperature to 195oC for the 5 wt% composite 
and to 200oC for the 10 wt% composite film. This initial reduction in mass could be due to the 
loss of water which was incorporated in the 45S5 Bioglass® mass, as described by Clupper 
and Hench.[36] Also for the composites (Figure S-2) the weight loss was rapid up to 250oC but 
remained constant after about 500oC, implying that at this point the entire polymer was burnt 
off and only n-BG was left.  
 
When investigated for in vitro degradation behaviour, the developed samples underwent 
surface degradation via abiotic non enzymatic hydrolysis occurring due to the cleavage of the 
ester bond in the P(3HO) backbone, typical of the PHA family. The % of water absorbed 
(WA) and weight loss (WL) by the films are depicted in Figure 2(a-d) respectively. Since, 
hydrolytic degradation of PHAs is known to be a slow process when compared to the 
enzymatic hydrolysis of PHAs [37], this explains why only a maximum weight loss of 18 % 
was observed for the P(3HO)/n-BG system as opposed to the control film which was 15 %. 
This low degradation is also due to the hydrophobic nature of the long alkyl pendant chains of 
the P(3HO) polymer.[38] The increased water absorption and weight loss demonstrated by the 
composites was due to its decreased crystallinity and the hydrophilic nature of the n-BG 
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particles. Similar results of increased water absorption and weight loss were observed for 
P(3HB)/n-BG composites.[25, 32] Surface studies of the degrading films using SEM (Figure 
2(g-h)), at the end of 4 months of incubation, showed degraded polymer surface with loose 
polymer flakes present on the surface, suggesting that the films underwent surface 
degradation. This surface degradation behaviour of the developed composites is also 
advantageous as opposed to polymeric matrices e.g. poly(glycolic acid-co-lactic acid) 
(PLGA) which undergo bulk degradation. In a skin tissue engineering situation, where the 
stability of the matrix/support is also crucial for delivering the keratinocyte epidermal layer in 
to the wound site, use of a bulk degrading matrix may be unfavourable and would lead to 
wound contraction due to premature loss of geometry of the matrix. On the other hand such 
wound contraction will be avoided using the developed P(3HO)/n-BG composite, which is 
able to maintain its geometry during degradation. Also, as the PHA family is bioresorbable, 
hence P(3HO)/n-BG matrix would be resorbed in the body, thus avoiding surgical 
intervention needed to remove the matrix support.  
Figure 2 
45S5 Bioglass® has been shown to have an antibacterial effect against S.aureus and  
S. epidermis which are bacterial strains found quite often in wound dressing. Pratten et al.[39] 
found that bacterial colonization decreased significantly on surgical sutures with bioactive 
glass coating, as compared to those without coating. This bactericidal effect of Bioglass® 
45S5 has been attributed to high pH caused by the dissolution of the alkali ions from the glass 
and an additional ion release.[40] In this present study, leaching of alkaline and calcium ions 
from the P(3HO)/n-BG system resulted in an increase of pH in both DMEM and PBS medium 
(Figure 2 (e-f)). The increase in pH of the P(3HO) control films occurred because all the 3HO 
molecules existed in the base form, i.e. 3-hydroxyoctanoate.[20] The pH of the media at the end 
of 4 months of incubation was around 9.2-9.4 in DMEM and 7.8 in PBS media. In addition, 
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the ion release products of Bioglass® particles have also been known to possess angiogenic 
potential. Achieving vascularizaton is crucial for the success of a functional tissue engineered 
construct.  The ion release products from the Bioglass® have been shown to up regulate the 
expression of angiogenic factors such as vascular endothelial growth factor (VEGF).[29, 30] In 
this respect the developed nanocomposite has yet another added advantage, as the ion release 
products from the nanocomposite films can also aid in the vascularisation of the engineered 
skin tissue construct.  
The bioactive glass nanoparticles used in this investigation were also found to be 
haemostatically active.  As reported by Ostomel et al. for mesoporous bioglass particles the 
haemostatic activity of the 45S5 Bioglass®  particles could also be due to its dual role of 
supplying calcium ions, which act as cofactors for initiating the blood clotting cascade, and 
also by providing a negatively charged siliceous oxide as a support for surface dependent 
thrombotic reactions. The bioglass particles accelerated the  time for blood clot formation, 
however, the clot formed was of reduced strength as opposed to the control (whole human 
blood only) (Table 2). This observation could be due to the low Si to Ca ratio for the n-BG 
which is 1.69. Ostomel et al. in their work demonstrated that the clotting time and the clot 
strength was affected by the composition of the bioglass; mesoporous bioglass particles with a 
high silicon (Si) to calcium (Ca) ratio of 80, was more haemostatic than that of Si to Ca ratio 
of 60.[31] From these studies it can therefore be hypothesized that the tissue engineered skin 
graft developed using these P(3HO)/n-BG nanocomposite matrices when grafted onto the 
wound site will provide healthy cells as well as prevent blood loss following tissue injury, due 
to the haemostatic effect of the bioactive glass nanoparticles, a great advantage.  
Table 2 
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Mammalian cells are anchorage dependent and need a biocompatible, protein rich surface for 
attachment, differentiation and migration to form new tissue.[25, 41, 42] Therefore, protein 
adsorption assay was carried out to indirectly evaluate cell adhesion and survival on the 
fabricated films. In this study, analysis was carried out using the whole protein serum. The 
amount of protein adsorbed on the films were: 5 wt% composite film = 140 µg/cm2, 5 wt% 
neat (control) film = 75 µg/cm2, 10 wt% composite film = 130 µg/cm2 and 10 wt % neat 
(control) film = 83 µg/cm2. The protein adsorption was significantly higher (n=4, **p<0.01) 
on the P(3HO)/n-BG composite films than on the P(3HO) neat (control) films. Surface 
properties of a material, both chemical composition and topographical features play an 
important role in the adsorption behaviour of proteins. Therefore, this increased adsorption of 
proteins on the composite films could be due to the incorporation of the n-BG which had 
increased the surface roughness, hydrophilicity and also the surface area of the composite 
exposed to proteins. This result is in agreement with the increased adsorption of proteins 
observed on composites of P(3HB)/n-BG,[25] nanoscale hydroxyapatite/PLLA composite film 
41 and fibrous nanoscale tricalcium phosphate/PLGA composite scaffolds.[43] This increased 
adsorption of proteins on the P(3HO)/n-BG composite system  also translated into improved 
biocompatibility of the composite as opposed to the control for the seeded HaCaT cells. The 
growth of HaCaT cells increased progressively with time, also better attachment and 
proliferation of cells on composite films was observed, as opposed to the P(3HO) control 
films. At day 7 there was a significant increase in the growth of cells on composite films 
when compared to neat (control) films and the control (n = 4, **p<0.05). Keratinocytes are 
known to form four distinct layers that divide and differentiate as they move from the deeper 
layer to the outermost layers. This arrangement of cell layers from the bottom to the 
outermost is as follows: (1) stratum basale (basal layer), (2) stratum spinulosum (spiny or 
prickle cell layer), (3) stratum granulosum (granular layer) and (4) stratum corneum (horn 
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sheet layer).[44] The morphology, attachment and proliferation of the seeded HaCaT cells on 
the fabricated films, as revealed via SEM, is shown in Figure 3(a-b). In the neat control films 
confluent growth was observed by day 4, Figure 3(c-d), however, horn sheets were only 
observed by day 7. Coherent horn sheets of the stratum corneum were observed by day 4 in 
both the 5 and 10 wt% composite films.  As horn sheets are the outermost and most mature or 
differentiated stage of the HaCaT cell line, this implies that the cells had successfully 
attached, proliferated and grown on the fabricated composite films, Figure 3(e-f).  
Figure 3 
 
These SEM observations confirm that the HaCaT cells were able to proliferate better on the 
composite films as opposed to the neat (control) films. It has been discussed in literature that a 
rough and hydrophilic surface provides a better matrix for cell attachment and proliferation.[35, 
45] Hence, the incorporation of the rough nanotopography, increased wettability and high 
surface area of the P(3HO)/n-BG composite system enabled improved adhesion, growth and 
proliferation of the HaCaT cells on the composite as opposed to the P(3HO) control. Similar 
observation of increased MG-63 osteoblast proliferation was observed for P(3HB)/n-BG 
composites, in comparison to the neat P(3HB) scaffolds, by Misra et al.[25] and increased 
proliferation of MC3T3-E1 osteoprogenitor cells on P(3HB-co-3HHx)/ hydroxyapatite 
scaffolds, when compared to P(3HB-co-3HHx) scaffold.[35] A schematic representation of the 
developed P(3HO)/n-BG nanocomposite as matrix support for engineering skin tissue is 
shown in Figure 4. 
Figure 4 
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4. Conclusions 
In summary we have developed a novel P(3HO)/n-BG nanocomposite system with numerous 
unique features including highly elastomeric nature, high surface topography and 
hydrophilicity, haemostatic properties, ability to enhance vascularization, antibacterial activity 
and high biocompatibility. The composite is amenable to thermal processing, revealed surface 
degradation properties, ideal for maintaining matrix integrity whilst undergoing degradation 
and exhibited the required elastomeric mechanical properties. Considering all these features in 
the newly developed P(3HO)/n-BG nanocomposite system, we conclude that this work has 
led to the development of a unique matrix with an extraordinary potential for engineering skin 
tissue.  
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Figure captions: 
Figure 1: SEM images of the P(3HO) neat (control) and P(3HO)/n-BG nanocomposite films: 
(a) cross section and (b) planar surface of a 5 wt % P(3HO) neat (control) film revealed a 
smooth surface. (c) cross section and (d) planar surface of a 5 wt % (P(3HO)/n-BG) 
composite film revealed a rough surface. Arrows indicate the surface of the fabricated 
matrices; dashed circle with asterisk highlight the rough surface topography of the  
P(3HO)/n-BG due to the presence of the n-BG particles and its corresponding agglomeration. 
Figure 2: In vitro degradation behaviour of the P(3HO)/n-BG and P(3HO) control samples 
showing the profiles for water absorption, weight loss and pH in DMEM medium  (a, c, e ) 
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and PBS medium (b, d, f). Surface degradation behaviour observed via SEM at the end of  
4 months of incubation in DMEM medium of a 5 wt% composite film (g) and a 5 wt % neat 
control film (h).   
Figure 3: SEM images of the seeded HaCaT cells on the fabricated films: (a-b) Seeded HaCaT 
cells showing attachment and proliferation on the film: (a) Magnification 2000X (b) 
Magnification 3000X; (c-d) Seeded HaCaT cells at day 4, on the neat film, confluent growth 
of the cells observed: (c) Magnification 2000X (d) Magnification 3000X; (e-f) Seeded HaCaT 
cells on day 7 on the composite film, arrangement of cells in horn sheets: (e) Magnification 
2000X (f) Magnification 3000X: (1) Uncovered polymer matrix, (2) Cell layer and  
(3) Spreading of the cells.  
Figure 4: Skin tissue regeneration based on a nanocomposite of P(3HO) and bioactive glass 
nanoparticles. 
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Supporting information: 
 
 
Figure S.1: Stress strain profile of the fabricated films: (A): 5 wt% composite film (B): 5 wt% 
neat film (control) (C): 10 wt% composite film (D): 10 wt% neat film (control). The films 
were subjected to a load between 200 to 6000 N which was increasing at the rate of 200N 
min-1.  
 
 
 
